DOSSIER · 13F-HR · Q1 2026

NEXTBio Capital Management LP

$215M in tracked AUM across 24 positions as of Q1 2026.

NC
CIK 0002038158 · last filed Mar 31, 2026
Total AUM
$215M
as of Q1 2026
Holdings
24
positions
Whale Score
59
59
tracked
Activity
no data
changes this Q
AI Analysis · Q1 2026

NEXTBio Capital Management LP filed its latest 13F-HR for Q1 2026. See the latest holdings and position changes below.

Quarter at a glance — Q1 2026

Position-change comparison pending.

No quarter-over-quarter changes available.

Top 10 holdings

By portfolio weight as of Q1 2026.

#HoldingValueSharesWeight
01
TERN
TERNS PHARMACEUTICALS INC
$32M605K14.8%
02
PTGX
PROTAGONIST THERAPEUTICS INC
$24M230K11.2%
03
STTK
SHATTUCK LABS INC
$20M3.1M9.4%
04
VOR
VOR BIOPHARMA INC
$18M1000K8.3%
05
CMPS
COMPASS PATHWAYS PLC
$11M2.0M5.2%
06
RYTM
RHYTHM PHARMACEUTICALS INC
$11M126K5.1%
07
XENE
XENON PHARMACEUTICALS INC
$11M183K4.9%
08
PVLA
PALVELLA THERAPEUTICS INC NE
$10M83K4.8%
09
ZBIO
ZENAS BIOPHARMA INC
$8M427K3.9%
10
IVA
INVENTIVA SA
$7M1.3M3.4%

Filing history

2026Q1Mar 31
$215M 26.3%
24 positionsView →
2025Q4Dec 31
$170M
23 positionsView →